Surfix develops a test method for corona diagnosis

Published on
December 22, 2020

Surfix, located at Wageningen Campus, together with their Dutch partners Lionix International and Qurin Diagnostics and supported by public-private partnership Photon Delta develops a test method for corona diagnosis and immunity detection.

The aim is to have SARS-CoV-2 testing devices in doctors’ offices, which yield reliable test results within 5 minutes. The device will be built around a photonic biochip using LioniX International’s proven silicon nitride based integrated optics technology (TriPleX™). The ultimate goal is to make a test for the masses- a widely available, disposable test, which can be read out in a hand-held PoC device and will only cost a few euros.

See the Surfix website for recent developments and background information about the new test method.

Surfix was founded in 2011 as a spin-off of the Organic Chemistry laboratory of Wageningen University & Research and is located in Plus Ultra on Wageningen Campus.